| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
2
2
2
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
D-
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 3.17 | 3.4 | -0.24 |
| Stocks | 1.48 | 0.0 | 1.48 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.0 | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 98.75 | 0.0 | 98.75 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Roche Holding AG | RHHVF | 23.65 | 4.1 |
| Sanofi | SAN | --- | 2.6 |
| Novartis AG | NVSEF | 17.5 | 2.39 |
| Nestle SA | NSRGF | 9.65 | 2.33 |
| Syngenta AG | SYENF | 46.22 | 2.22 |
| Swiss Re AG | SREN | --- | 2.16 |
| Barclays PLC ADR | BCS | 4.44 | 2.09 |
| Orix Corporation | ORXCF | -84.98 | 2.06 |
| Glencore International PLC | GLCNF | -16.9 | 1.91 |
| AIA Group Ltd. | AAIGF | --- | 1.76 |
